Clinical Research
Our clinical research advances treatments and technologies that work for LGBTQ people as well as offer expands access to treatments for patients who need them. ERA participates in drug and device research, ranging from Phase II-IV, focusing on Infectious Diseases. This scope of our research advances HIV/AIDS, intervention (PrEP), Anal Dysplasia and sexually transmitted infections through treatment, prevention, diagnostic, screening and quality of life studies.
The ERA research team has participated in research that is vital to the HIV impacted population, helping to bring highly safe and effective treatment options to our community, as well as innovative medications for salvage therapy. In addition, we participate in HIV treatment simplification research to identify better strategies to care for people living with HIV.
If you are interested in volunteering for a current study, please check our currently enrolling studies for our opportunities.
Clinical Research Team
Kenyetta Sims, MAOM, CCRC
Director of Clinical Research
(any respectfully)
Ebony Warren, Sr. CRC
Manager of Clinical Research
(she/her/hers)
Patrice Collins, DPT, CCRC
Clinical Research Coordinator
(she/her/hers)
Leo Leal, BA, CRC
Clinical Research Coordinator
(he/him/his)
John Gould, BS
COVID Research Navigator
(he/him/his)
Clinical Research Collaborations
We are grateful for our partners:
- Gilead Sciences
- Janssen Pharmaceuticals
- ViiV Healthcare
- Abbott Laboratories
- Abbott Point of Care
- Thera Technologies
- Inovio Pharmaceuticals
- CytoDyn, Inc
- Merck, INC.